WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2004009088) 4-(4-METHYLPIPERAZIN-1-YLMETHYL)-N-[4-PYRIDIN-3-YL)PYRIMIDIN-2-YLAMINO)PHENYL]-BENZAMIDE FOR TREATING ANAPLASTIC THYROID CANCER
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2004/009088    International Application No.:    PCT/IB2003/001985
Publication Date: 29.01.2004 International Filing Date: 23.05.2003
Chapter 2 Demand Filed:    24.01.2004    
IPC:
A61K 9/48 (2006.01), A61K 31/506 (2006.01)
Applicants: NOVARTIS AG [CH/CH]; Lichstrasse 35, CH-4056 Basel (CH) (AE, AG, AL, AM, AU, AZ, BA, BB, BE, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CY, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, FR, GB, GD, GE, GH, GR, HR, HU, ID, IE, IL, IN, IS, IT, JP, KE, KG, KP, KR, KZ, LC, LK, LT, LU, LV, MA, MC, MD, MK, MN, MX, NI, NL, NO, NZ, OM, PH, PL, PT, RO, RU, SC, SE, SG, SI, SK, TJ, TM, TN, TR, TT, UA, UZ, VC, VN, YU, ZA, ZW only).
NOVARTIS PHARMA GMBH [AT/AT]; Brunner Strasse 59, A-1230 Vienna (AT) (AT only).
OHTSURU, Akira [JP/JP]; (JP).
PODTCHEKO, Alexei [RU/JP]; (JP).
TSUDA, Satoshi [JP/JP]; (JP).
YAMASHITA, Shunichi [JP/JP]; (JP)
Inventors: OHTSURU, Akira; (JP).
PODTCHEKO, Alexei; (JP).
TSUDA, Satoshi; (JP).
YAMASHITA, Shunichi; (JP)
Agent: GRUBB, Philip; Novartis AG, Corporate Intellectual Property, Patent and Trademark Department, CH-4002 Basel (CH)
Priority Data:
60/398,410 24.07.2002 US
60/454,557 14.03.2003 US
Title (EN) 4-(4-METHYLPIPERAZIN-1-YLMETHYL)-N-[4-PYRIDIN-3-YL)PYRIMIDIN-2-YLAMINO)PHENYL]-BENZAMIDE FOR TREATING ANAPLASTIC THYROID CANCER
(FR) 4-(4-METHYLPIPERAZIN-1-YLMETHYL)-N-[4 METHYL-3-(4-PYRIDIN-3YL)PYRIMIDIN-2-YLAMINO)PHENYL] BENZAMIDE UTILISE POUR LE TRAITEMENT DES CANCERS ANAPLASIQUES DE LA THYROIDE
Abstract: front page image
(EN)The invention relates to the use of 4-(4-methylpiperazin-1-ylmethyl)-N-[4 methyl-3-(4-pyridin-3yl)pyrimidin-2-ylamino)phenyl] benzamide of the following formula or a pharmaceutically acceptable salt thereof for the manufacture of a medicament for the treatment of anaplastic thyroid cancers.
(FR)L'invention concerne l'utilisation de 4-(4-méthylpipérazin-1-ylméthyl)-N-[4 méthyl-3-(4-pyridin-3yl)pyrimidin-2-ylamino)phényl] benzamide représenté par la formule (1) ou d'un sel pharmaceutiquement acceptable dudit composé pour la fabrication d'un médicament pour le traitement des cancers anaplasiques de la thyroïde.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LT, LU, LV, MA, MD, MK, MN, MX, NI, NO, NZ, OM, PH, PL, PT, RO, RU, SC, SE, SG, SK, TJ, TM, TN, TR, TT, UA, US, UZ, VC, VN, YU, ZA, ZW.
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PT, RO, SE, SI, SK, TR).
Publication Language: English (EN)
Filing Language: English (EN)